These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9732941

  • 1. Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.
    Banner BF, Karamitsios N, Smith L, Bonkovsky HL.
    Am J Gastroenterol; 1998 Sep; 93(9):1541-5. PubMed ID: 9732941
    [Abstract] [Full Text] [Related]

  • 2. [Computerized histological analysis in chronic viral hepatitis].
    Hassan C, Tavani PD, Serafini B.
    Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR, Millward-Sadler GH, Barbatis C, Wright R.
    N Engl J Med; 1981 Mar 05; 304(10):557-60. PubMed ID: 6969850
    [Abstract] [Full Text] [Related]

  • 5. A patient with autoimmune hepatitis type I, Addison's disease, atrophic thyroiditis, atrophic gastritis, exocrine pancreatic insufficiency, and heterozygous alpha1-antitrypsin deficiency.
    Bergwitz C, Brabant G, Trautwein C, Manns MP.
    Am J Gastroenterol; 2002 Apr 05; 97(4):1050-2. PubMed ID: 12003388
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.
    Kok KF, Wahab PJ, Houwen RH, Drenth JP, de Man RA, van Hoek B, Meijer JW, Willekens FL, de Vries RA.
    Neth J Med; 2007 May 05; 65(5):160-6. PubMed ID: 17519511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S, Foli M, Di Tomaso M, Gramantieri L, Masci C, Bolondi L.
    Ital J Gastroenterol Hepatol; 1999 Mar 05; 31(2):130-4. PubMed ID: 10363198
    [Abstract] [Full Text] [Related]

  • 12. [Hepatitis C treatment without liver biopsy].
    Siboni A.
    Ugeskr Laeger; 2002 Mar 11; 164(11):1522-3; discussion 1523-4. PubMed ID: 11924484
    [No Abstract] [Full Text] [Related]

  • 13. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S, Thorburn D, Anderloni A, Ardizzone S, Giorgi A, Bianchi Porro G, Parente F.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):209-15. PubMed ID: 16091058
    [Abstract] [Full Text] [Related]

  • 14. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
    Nguyen HV, Mollison LC, Taylor TW, Chubb SA, Yeap BB.
    Intern Med J; 2006 Jun 01; 36(6):362-6. PubMed ID: 16732861
    [Abstract] [Full Text] [Related]

  • 15. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Yakabi S.
    Hepatogastroenterology; 2003 Jun 01; 50(49):165-9. PubMed ID: 12630015
    [Abstract] [Full Text] [Related]

  • 16. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF, Said AT, Cummings OW, Born LJ.
    Am J Gastroenterol; 2000 Sep 01; 95(9):2328-32. PubMed ID: 11007237
    [Abstract] [Full Text] [Related]

  • 17. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M, Rodriguez M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Lopez-Rubio F, de la Mata M, Aljama P.
    Clin Nephrol; 2001 Mar 01; 55(3):220-6. PubMed ID: 11316242
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
    Itoh Y, Okanoue T, Ohnishi N, Sakamoto M, Nishioji K, Nakagawa Y, Minami M, Murakami Y, Kashima K.
    Am J Gastroenterol; 1999 May 01; 94(5):1332-40. PubMed ID: 10235215
    [Abstract] [Full Text] [Related]

  • 19. Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
    Coverdale SA, Khan MH, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Liddle C, Kench JG, Crewe E, Farrell GC.
    Am J Gastroenterol; 2004 Apr 01; 99(4):636-44. PubMed ID: 15089895
    [Abstract] [Full Text] [Related]

  • 20. Treatment with alpha-interferon in chronic hepatitis.
    Matei I, Tănăsescu C, Voiosu R, Murariu E, Dragomir P, Serbănescu A.
    Rom J Intern Med; 1998 Apr 01; 36(3-4):227-37. PubMed ID: 10822519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.